Premium
British Society for Haematology guidelines for the management of adult myelodysplastic syndromes
Author(s) -
Killick Sally B.,
Ingram Wendy,
Culligan Dominic,
Enright Helen,
Kell Jonathan,
Payne Elspeth M.,
Krishnamurthy Pramila,
Kulasekararaj Austin,
Raghavan Manoj,
Stanworth Simon J.,
Green Simone,
Mufti Ghulam,
Quek Lynn,
Cargo Catherine,
Jones Gail L.,
Mills Juliet,
Sternberg Alex,
Wiseman Daniel H.,
Bowen David
Publication year - 2021
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17612
Subject(s) - medicine , myelodysplastic syndromes , guideline , azacitidine , cytopenia , decitabine , hemotherapy , transplantation , lenalidomide , intensive care medicine , oncology , family medicine , bone marrow , pathology , biochemistry , gene expression , chemistry , dna methylation , multiple myeloma , gene
0.1 12.10.09 Draft developed by Dr Juliet Mills (JM). Presented at Haematology NSSG. 0.2 14.10.09 Reformatted by Lara Barnish (LB) for comment and approval by JM. 0.3 17.10.09 With comments from JM. 0.4 09.10.09 Presented at the Clinical Governance Sub-Group. Minor formatting changes recommended. For consultation with Andrew Stanley (AS) and review by JM. 0.5 16.03.10 With changes from JM and approved by AS 0.5 07.05.10 To Haematology NSSG for final comment 1.0 21.05.10 Final Version with AS comments included. Resubmitted to the guidelines subgroup. 1.1 28.04.11 With amendment by Juliet Mills for re-approval by the Clinical Governance Committee. 2.0 10.05.11 Endorsed by the Governance Committee